Dr Paul E Smith, MD in Orofino, ID - Surgery

Dr Paul E Smith, MD is a Surgery physician based in Orofino, Idaho. Dr Paul E Smith is licensed to practice in Idaho (license number M8178) and his current practice location is 4042 Eureka Ridge Rd, Orofino, Idaho. He can be reached at his office (for appointments etc.) via phone at (208) 476-7630.

NPI number for Dr Paul E Smith is 1396740593 and his current mailing address is 4042 Eureka Ridge Rd, Orofino, Idaho. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1396740593.

Contact Information

	Dr Paul E Smith, MD
	4042 Eureka Ridge Rd, Orofino, ID 83544-9547
	(208) 476-7630
	Not Available

Physician's Profile

Full Name	Dr Paul E Smith
Gender	Male
Speciality	Surgery
Location	4042 Eureka Ridge Rd, Orofino, Idaho
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1396740593
Provider Enumeration Date: 06/15/2005
Last Update Date: 11/28/2007

Medical Identifiers

Medical identifiers for Dr Paul E Smith such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396740593	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	M8178 (Idaho)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Paul E Smith is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Paul E Smith, MD 4042 Eureka Ridge Rd, Orofino, ID 83544-9547 Ph: (208) 476-7630	Dr Paul E Smith, MD 4042 Eureka Ridge Rd, Orofino, ID 83544-9547 Ph: (208) 476-7630

News Archive

HGSI, FivePrime enter agreement to develop, commercialize FP-1039 for multiple cancers

Human Genome Sciences, Inc. and FivePrime Therapeutics, Inc. announced today that they have entered into an agreement to develop and commercialize FivePrime's FP-1039 product for multiple cancers.

RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

RTI Health Solutions, a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity.

Research findings point to potential drug targets to improve angiogenesis in diabetes patients

Diabetes heightens the risk of vascular damage to heart and limbs, and impairs the ability to repair damage with new growth of blood vessels, called angiogenesis.

Starch-based intravenous fluids cause unnecessary deaths in seriously ill patients

Starch-based intravenous (IV) fluids used by the NHS to treat seriously ill patients are causing unnecessary deaths, according to a new Cochrane systematic review by researchers at the London School of Hygiene & Tropical Medicine.

Merck acquires development, commercialization rights of ridaforolimus

Merck today announced that it has restructured its co-development and co-commercialization agreement with ARIAD Pharmaceuticals, Inc. for ridaforolimus, an investigational orally available mTOR inhibitor currently being evaluated for the treatment of multiple cancer types, to an exclusive license agreement.

Surgery Doctors in Orofino, ID

Karin Schmidova, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 301 Cedar St, Orofino, ID 83544
Phone: 208-476-4555 Fax: 208-476-5385

Dr Paul E Smith, MD - Surgery in Orofino, ID